EFSA suspends novel food applications due to ‘data gaps and uncertainties’ 

lab tests

The European Food Safety Authority (EFSA) has ‘stopped the clock’ on 19 novel food applications for CBD, pending new data. The EU authority says its scientists cannot currently establish the safety of CBD as a novel food due to data gaps and uncertainties about potential hazards related to CBD intake. The news follows the submission […]

UK CBD sector on standby for release of FSA’s list of permitted products

The UK’s consumer health sector is set for its biggest shake-up in more than a decade when the Food Standards Agency (FSA) releases its eagerly-awaited public list of CBD products permitted for sale to consumers. Only products on the list will be able to stay on the market, while those not included will have to […]

FSA issues clarification and new deadline for toxicology data

A number of CBD companies have until 28 February to provide sufficient toxicology data to the Food Standards Agency, or risk losing the right to sell their products.  Cannabinoid Insight has learnt that up to 40 CBD companies which submitted summary data on epilepsy drug Epidiolex in their novel foods application, have until 28 February […]

How safe is CBD?

Widely available in an array of formats across the wellness category, the rise of this hemp extract in consumer products begs the question – how safe is CBD? Years of consumption of CBD have provided a wealth of information about safety. – Toxicology expert, Dr Paul Duffy Skincare and cosmetics When it comes to applying […]

How to train a workforce in CBD

Often used as a weapon against misinformation by CBD brands, education is an essential tool in combatting years of erroneous claims about the cannabis plant.  From the endocannabinoid system to manufacturing practices, unique selling points and getting that retail pitch perfect – CBD can present a never-ending learning curve for those new to this arena. […]

British Cannabis snags Elixinol license

Australian CBD brand, Elixinol, is set to return to the UK market, following a new licensing and distribution agreement with British Cannabis. In 2021, Elixinol announced plans to cease trading in the UK and European Union in order to focus its attention on the US and Australian markets. The company said that decision was down […]